Ovid Therapeutics Inc. Share Price
NASDAQ: OVID | Micro CapOvid Therapeutics Inc. Stock Performance
Open $2.91 | Prev. Close $2.84 | Circuit Range N/A |
Day Range $2.84 - $2.94 | Year Range $0.84 - $3.10 | Volume 2,83,776 |
Average Traded $2.89 |
Ovid Therapeutics Inc. Share Price Today
As of 20 August 2026, Ovid Therapeutics Inc.'s share price is $2.95. The stock opened at $2.91, compared to its previous close of $2.84. During today's trading session, Ovid Therapeutics Inc.'s share price traded between $2.84 and $2.94, with an average price of $2.89. Over the past 52 weeks, the stock has recorded a high of $3.10 and a low of $0.84. In terms of performance, Ovid Therapeutics Inc.'s share price has risen by 80.43% over the last six months and is up 130.47% on a year-on-year basis.
Ovid Therapeutics Inc. Share Price Chart
Ovid Therapeutics Inc. Stock Fundamentals & Key Indicators
Market Cap $217.52M | PE Ratio (TTM) -12.83 | Dividend Yield N/A |
EPS (TTM) $-0.23 | Revenue (TTM) $7.25M | Return On Equity (TTM) -13.33% |
Profit Margin -240.13% | Debt to Equity 0.06 | Quarterly Earnings Growth YoY N/A |
About Ovid Therapeutics Inc.
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Ovid Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.30 | $2.85 | +29.32% |
Jul 2026 | $2.70 | $2.20 | -18.22% |
Jun 2026 | $2.72 | $2.69 | -1.82% |
May 2026 | $2.78 | $2.74 | -1.08% |
Apr 2026 | $2.23 | $2.77 | +25.06% |
Mar 2026 | $1.58 | $2.21 | +35.47% |
Feb 2026 | $1.58 | $1.64 | +5.14% |
Jan 2026 | $1.61 | $1.55 | -4.31% |
Dec 2025 | $1.73 | $1.63 | -8.71% |
Nov 2025 | $1.40 | $1.78 | +27.14% |
Oct 2025 | $1.30 | $1.40 | +8.11% |
Sep 2025 | $1.21 | $1.29 | +1.17% |
OVID Share Price FAQs
What is Ovid Therapeutics Inc. share price today?
What is the 52 week high and 52 week low of Ovid Therapeutics Inc. stock?
What is OVID's market capitalisation today?
What is the 5 year returns of OVID?
What is the high & low stock price of OVID today?
Can I buy OVID shares in India?